Glypican 3-targeted chimeric antigen receptor T cells secreting TROP2-directed bispecific T cell engagers exhibit potent efficacy against lung squamous cell carcinoma

BackgroundChimeric antigen receptor T cell (CAR-T) therapy faces multiple challenges in solid tumors, especially the heterogeneity of tumor antigens. Glypican-3 (GPC3) and trophoblast cell-surface antigen 2 (TROP2) are highly expressed antigens in lung squamous cell carcinoma (LUSC) for development...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lianjie Ruan, Liming Lin, Dekai Lin, Haiqing Zhang, Suiyan Weng, Mengqing Lin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-01-01
coleção:	Frontiers in Immunology
Assuntos:	BiTE CAR-T GPC3 lung squamous cell carcinoma TROP2
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1709316/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!